Genomic Medicine Group, J. Craig Venter Institutegrid.469946.0, La Jolla, California, USA.
Department of Pediatrics, University of California at San Diego, La Jolla, California, USA.
J Bacteriol. 2022 May 17;204(5):e0004222. doi: 10.1128/jb.00042-22. Epub 2022 Apr 11.
Streptococcus mutans is considered a primary etiologic agent of dental caries, which is the most common chronic infectious disease worldwide. S. mutans B04Sm5 was recently shown to produce reutericyclins and mutanocyclin through the biosynthetic gene cluster and to utilize reutericyclins to inhibit the growth of neighboring commensal streptococci. In this study, examination of S. mutans and phylogeny suggested evolution of an ancestral S. mutans into three lineages within one S. mutans clade and then horizontal transfer of to other S. mutans clades. The roles of the mucG and mucH transcriptional regulators and the mucI transporter were also examined. was demonstrated to encode a transcriptional activator of . deletion reduced production of mutanocyclin and reutericyclins and eliminated the impaired growth and inhibition of neighboring streptococci phenotypes, which are associated with reutericyclin production. Δ had increased mutanocyclin and reutericyclin production, which impaired growth and increased the ability to inhibit neighboring streptococci. However, deletion of also caused reduced expression of , , and Deletion of reduced mutanocyclin and reutericylin production but enhanced growth, suggesting that may not transport reutericyclin as its homolog does in Limosilactobacillus reuteri. Further research is needed to determine the roles of and and to identify any cofactors affecting the activity of the and regulators. Overall, this study provided pangenome and phylogenetic analyses that serve as a resource for S. mutans research and began elucidation of the regulation of reutericyclins and mutanocyclin production in S. mutans. S. mutans must be able to outcompete neighboring organisms in its ecological niche in order to cause dental caries. S. mutans B04Sm5 inhibited the growth of neighboring commensal streptococci through production of reutericyclins via the biosynthetic gene cluster. In this study, an S. mutans pangenome database and updated phylogenetic tree were generated that will serve as valuable resources for the S. mutans research community and that provide insights into the carriage and evolution of S. mutans The MucG and MucH regulators, and the MucI transporter, were shown to modulate production of reutericyclins and mutanocyclin. These genes also affected the ability of S. mutans to inhibit neighboring commensals, suggesting that they may play a role in S. mutans virulence.
变形链球菌被认为是龋齿的主要病因,龋齿是全球最常见的慢性传染病。最近的研究表明,B04Sm5 能够通过生物合成基因簇产生雷替辛和突变环素,并利用雷替辛抑制相邻共生链球菌的生长。在这项研究中,对变形链球菌的研究和系统发育分析表明,祖先变形链球菌在一个变形链球菌分支内进化为三个谱系,然后横向转移到其他变形链球菌分支。还研究了 mucG 和 mucH 转录调节剂和 mucI 转运蛋白的作用。结果表明,编码突变环素和雷替辛生物合成基因簇的转录激活子。突变环素和雷替辛的产量降低,并且消除了与雷替辛产生相关的生长受损和对相邻链球菌的抑制表型。突变体的突变环素和雷替辛产量增加,从而抑制了生长并增加了抑制相邻链球菌的能力。然而,突变体的突变环素和雷替辛产量也降低,表明可能不像 Limosilactobacillus reuteri 中的同源物那样运输雷替辛。需要进一步研究以确定和的作用,并确定任何影响和调节剂活性的协同因子。总的来说,这项研究提供了变形链球菌的泛基因组和系统发育分析,为变形链球菌的研究提供了资源,并开始阐明变形链球菌中雷替辛和突变环素的产生的调控。为了引起龋齿,变形链球菌必须能够在其生态位中与相邻的生物体竞争。B04Sm5 通过生物合成基因簇产生雷替辛抑制了相邻共生链球菌的生长。在这项研究中,生成了一个变形链球菌泛基因组数据库和更新的系统发育树,它们将作为变形链球菌研究社区的有价值资源,并提供了有关变形链球菌携带和进化的见解。MucG 和 MucH 调节剂和 MucI 转运蛋白被证明可以调节雷替辛和突变环素的产生。这些基因也影响了变形链球菌抑制相邻共生菌的能力,表明它们可能在变形链球菌的毒力中起作用。